Vitrafy Life Sciences Limited (ASX:VFY)
Australia · Delayed Price · Currency is AUD 3.810
+0.010 (0.26%)
Aug 26, 2026, 3:58 PM AEST
Vitrafy Life Sciences Market Cap
Vitrafy Life Sciences has a market cap or net worth of 289.56 million as of August 25, 2026. Its market cap has increased by 212.76% in one year.
Market Cap
289.56M
Enterprise Value
248.64M
Revenue
209.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.81
ChartMarket Cap Chart
Since November 26, 2024, Vitrafy Life Sciences's market cap has increased from 126.42M to 289.56M, an increase of 129.04%. That is a compound annual growth rate of 60.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 289.56M | 254.29% |
| Dec 30, 2025 | 81.73M | -24.71% |
| Dec 31, 2024 | 108.54M | -14.14% |
| Nov 26, 2024 | 126.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cuscal | 1.14B |
| FINEOS Corporation Holdings | 800.50M |
| Aura Consolidated Group | 742.52M |
| Tyro Payments | 435.99M |
| Acusensus | 218.31M |
| Wrkr Ltd | 155.66M |
| Decidr AI Industries | 128.66M |
| EML Payments | 100.61M |